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Unconventional Maturation of Dendritic Cells Induced by Particles
from the Laminated Layer of Larval Echinococcus granulosus
Cecilia Casaravilla,a Álvaro Pittini,a Dominik Rückerl,b Paula I. Seoane,a Stephen J. Jenkins,b* Andrew S. MacDonald,b*
Ana M. Ferreira,a Judith E. Allen,b Álvaro Díaza
Cátedra de Inmunología, Departamento de Biociencias (Facultad de Química) e Instituto de Química Biológica (Facultad de Ciencias), Universidad de la República,
Montevideo, Uruguaya; Institute of Immunology and Infection Research, Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of
Edinburgh, Edinburgh, United Kingdomb
The larval stage of the cestode parasite Echinococcus granulosus causes hydatid disease in humans and livestock. This infection is
characterized by the growth in internal organ parenchymae of fluid-filled structures (hydatids) that elicit surprisingly little in-
flammation in spite of their massive size and persistence. Hydatids are protected by a millimeter-thick layer of mucin-based ex-
tracellular matrix, termed the laminated layer (LL), which is thought to be a major factor determining the host response to the
infection. Host cells can interact both with the LL surface and with materials that are shed from it to allow parasite growth. In
this work, we analyzed the response of dendritic cells (DCs) to microscopic pieces of the native mucin-based gel of the LL (pLL).
In vitro, this material induced an unusual activation state characterized by upregulation of CD86 without concomitant upregu-
lation of CD40 or secretion of cytokines (interleukin 12 [IL-12], IL-10, tumor necrosis factor alpha [TNF-], and IL-6). When
added to Toll-like receptor (TLR) agonists, pLL-potentiated CD86 upregulation and IL-10 secretion while inhibiting CD40 up-
regulation and IL-12 secretion. In vivo, pLL also caused upregulation of CD86 and inhibited CD40 upregulation in DCs. Con-
trary to expectations, oxidation of the mucin glycans in pLL with periodate did not abrogate the effects on cells. Reduction of
disulfide bonds, which are known to be important for LL structure, strongly diminished the impact of pLL on DCs without alter-
ing the particulate nature of the material. In summary, DCs respond to the LLmucin meshwork with a “semimature” activation
phenotype, both in vitro and in vivo.
The larval stage (hydatid) of the cestode platyhelminth parasiteEchinococcus granulosus causes cystic echinococcosis (hydatid
disease) in a range of livestock species and also in humans (1).
Hydatids are fluid-filled, bladder-like structures that dwell in the
parenchyma of internal organs, most commonly the liver and
lungs, and can, over years or decades, reach tens of centimeters in
diameter (2). Their defining feature is the hydatid wall that sur-
rounds the fluid-filled cavity, composed of a thin inner layer of
cells (the germinal layer) and an outer, thick, protective acellular
layer (the laminated layer [LL]).
Immunologically, hydatid disease constitutes a striking puzzle,
since in spite of the parasite’s size, systemic anatomical location,
and persistence and the presence of detectable parasite-specific
(antibody and proliferative) responses, the parasite normally
thrives surrounded by a noninfiltrated host-derived collagen cap-
sule (3). The strong suppressive mechanisms at play in this infec-
tion are still undefined, but clues include the high levels of expres-
sion of the anti-inflammatory cytokine interleukin 10 (IL-10) by
leukocytes near the parasite (4) and the capacity of lymph node
cells from infected mice to transfer the suppression of antibody re-
sponses to unrelated antigens (5). Importantly, both of these regula-
tory activities are present in animals in which hydatids are surgically
implanted, indicating that exposure to the prehydatid parasite stages
is dispensable for induction of these processes. In addition, a strong
relative expansion of FoxP3 regulatory T cells in the spleen and
blood of infectedmice has been recently reported (6).
Healthy hydatids expose the host immune system only to sol-
uble excretory/secretory products (as yet largely uncharacterized)
and the massive, carbohydrate-rich LL, which can attain over 2
mm in thickness.With variations, the LL is present in all species of
the genus Echinococcuswhile it is absent fromother larval cestodes
(2, 3). It is essentially a meshwork of mucins giving rise to an
aqueous gel (2, 7). In E. granulosus, but probably not in the other
species, the LL additionally contains dispersed nanodeposits of the
calcium salt of inositol hexakisphosphate (8–10). The mucin
backbones, deduced from the germinal layer transcriptome (2, 11,
12), comprise highly glycosylated domains and short nonglycosy-
lated N-terminal extensions. Certain of these N-terminal exten-
sions bear unpaired cysteine residues, coincident with evidence
that disulfide bonds contribute to the LL structure (7). The LL
mucin glycans are now largely defined (13, 14).
The LL is widely considered to be the crucial element of larval
echinoccocal infections (3, 15, 16), including infection by Echino-
coccus multilocularis, the causative agent of life-threatening alveo-
lar echinococcosis (1). In addition to protecting the parasite from
host immune cells (17), the LL likely contributes to the downregu-
lation of inflammatory responses mounted earlier in infection
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against the establishing larvae (3, 18, 19). Given the key role played
by the innate immune system in coordinating inflammatory re-
sponses, theway inwhich innate immunity decodes, and responds
to, LL components is a central piece of the puzzle of larval Echi-
nococcus immunology. The issue has been addressed for the com-
plement system, where triggering of this cascade by the LL ismuch
less effective than that by other E. granulosusmaterials (3, 20, 21).
For innate immune cells, two studies focusing on nitric oxide pro-
duction bymacrophages showed that LL-derivedmaterials inhibit
this response in cells stimulated with lipopolysaccharide (LPS) or
gamma interferon (IFN-) (22, 23).
Immune cells can interact both with the outer surface of the LL
and with shed materials, as shedding of LL components is neces-
sary for the hydatid to grow (2). Given the drastic treatments that
need to be applied to the E. granulosus LL to achieve solubilization
in vitro (7), it is most likely that in vivo shedding involves partic-
ulate, rather than soluble, LL remnants. In experimental mouse
infections, periparasitic host macrophages have been observed to
phagocytose LL-derived particles (24, 25). Recently, abundant
particulate LL-derived materials have been detected in tissue sec-
tions from patients infected by E. multilocularis (26). These parti-
cles can be foundmillimeters away from the LL itself, including in
lymph nodes draining the infected organ.
We generated particles from the E. granulosusmucin-based gel
and analyzed their impact on the activation phenotype of murine
dendritic cells (DCs). Our results show that LL particles induce an
unconventional “semimature” phenotype in DCs. Surprisingly,
LL carbohydrates appear to be dispensable for these effects, while
treatments reducing disulfide bonds in the LL materials impaired
their ability to induce even this limited maturation state.
MATERIALS AND METHODS
Preparation of the pLL. The starting material for preparation of the mu-
cin-enriched particulate preparation from the LL (pLL) consisted of hy-
datid walls from macroscopically healthy, fertile (i.e., protoscolex-pro-
ducing) hydatids. Hydatid walls are in practice equivalent to LL, as the
contribution of the very thin germinal layer is negligible (3). The hydatid
material used was of Uruguayan origin and was from natural infections in
cattle or, where indicated, frommice infected intraperitoneally with pro-
toscoleces. The hydatid walls were extensively washed with phosphate-
buffered saline (PBS) and then 2MNaCl. The walls were then dehydrated
and finely ground using a mortar and pestle, followed by grinding be-
tween two polished glass plates. The resulting fine powders were carefully
rehydrated in pyrogen-free PBS containing 30 mM EDTA (1 ml for every
2 mg dry mass) to extract the calcium InsP6 deposits (10), sequentially
filtered through 85- and 23-m gauze, and then extensively washed in
pyrogen-free PBS, with centrifuging at 3,000 g for 5min each time. The
dehydration was carried out either with ethanol and acetone as described
previously (9) (EA-pLL) or by freeze-drying (FD-pLL). In addition, we
tested pLL prepared by a method that did not involve a dehydration step,
namely, shreddingwith a Tissue-ruptor blender (Qiagen) and then apply-
ing mild sonication (SS-pLL). The LL dry mass content of each prepara-
tionwas calculated by freeze-drying andweighing a portion of suspension
previously freed from salts by extensive washes with water. Visualization
of the preparations under a lightmicroscopewas carried out after staining
with the lectin PNA labeledwith fluorescein (Vector Laboratories) (7). All
pLL preparations were kept at 4°C as suspensions in PBS with penicillin-
streptomycin. Two different pLL preparations tested negative for endo-
toxin by the Limulus amebocyte lysate (LAL) method (0.03 endotoxin
units/ml for a dilution equivalent to the maximum pLL dose used with
cells). In agreement, neither pLL preparations nor the supernatants of the
last washes with PBS mentioned above elicited IL-12p40 or IL-10 from
DCs (in excess of the minimal cytokine levels detected for cells incubated
with medium alone).
Treatments applied to pLL. FD-pLL (from a bovine ormouse host, as
indicated in each case) was subjected to a series of treatments. To remove
strongly bound antibodies, pLL was suspended in 200 mM glycine-HCl,
pH 2, and incubated for 2 h at 50°C with occasional vortexing. To oxidize
carbohydrates, pLL was suspended in 50 mM sodium acetate, pH 4.5,
containing 10 mM sodium metaperiodate and incubated for 1 h at room
temperature with stirring. Then, to reduce and thus stabilize aldehyde
groups formed, an equal volume of 200mMsodiumborohydride inwater
(pHunadjusted) was added, and the suspensionwas incubated for 30min
at room temperature with stirring. A mock treatment was also applied, in
which metaperiodate was omitted from the acetate buffer step but the
borohydride reduction was applied as for the oxidative treatment. De-
struction of terminalmonosaccharideswas verified in terms of abrogation
of the binding of the plant lectins PNA and RCA1, known to bind the LL
sugars (7). For probing in dot blot format, pLL was previously solubilized
as described previously (7). For nonspecific proteolysis, pLL was sus-
pended in 20mMTris-HCl, pH8.0, containing 125g/ml proteinase type
XIV from Streptomyces griseus (pronase; Sigma) and incubated for 18 h at
37°C. For reduction of disulfides, pLLwas suspended in 50mMTris-HCl,
pH 8.0, buffer containing 50mMdithiotreitol (DTT) and incubated for 1
h at 37°C with occasional stirring. After a single wash with water, pLL was
resuspended in 100 mM iodoacetamide (IAA) in the same buffer (to al-
kylate free thiols) and incubated for 1 h at room temperature in the dark.
The pLL suspensions were transferred to pyrogen-free water before all
treatments and transferred back into pyrogen-free PBS by extensive wash-
ing after the treatments. In the case of proteolytic treatment, it was verified
that no proteolytic activity, detectable using the N-suc-Ala-Ala-Phe-7-
amido-4-methylcoumarin fluorogenic substrate (Sigma), remained after
the fourth posttreatment wash.
BMDC generation. Murine bone-marrow-derived dendritic cells
(BMDCs) were generated by differentiation of bone marrow precursors
from 8- to 10-week-old C57BL/6 mice for 10 days in the presence of 20
ng/ml recombinant mouse GM-CSF (PeproTech) as described in refer-
ence 27. The cells obtainedwere between 85 and 95%CD11c. On day 10,
cells were plated at 0.4, 1, or 2million perwell in 96-, 48-, or 24-well plates,
respectively, and stimuli were added inmedium containing 5 ng/ml gran-
ulocyte-macrophage colony-stimulating factor (GM-CSF).
Exposure of BMDCs to pLL and other stimuli. Doses of pLL and its
variants throughout this work are given in terms of g total dry mass per
million cells. These figures are at least an order of magnitude higher than
those we would give if we had chosen to express doses in terms of the
protein content, since (i) the LL ismostly carbohydrate and (ii) the freeze-
drying used to estimate dry mass does not remove all the water from this
highly hydrophilic material. When used together with Toll-like receptor
(TLR) agonists (10 ng/ml LPS from Escherichia coliO127:B8 [Sigma]; 100
ng/ml Pam3CSK [Invivogen]) or whole heat-killed Propionibacterium ac-
nes (10 g/ml total dry mass), pLL was added to the cells 1 h before the
inflammatory stimulus unless otherwise specified. Cell responses (cyto-
kines in supernatants or expression of cell surface molecules) were as-
sessed 18 h after the last stimulus was added. The blocking antibody
against FcRII/III (CD16/CD32) was from BD and was used at 5 g/ml.
Cytochalasin D was purchased from Sigma and used at 5 M. Cell viabil-
itywasanalyzedon thebasisof exclusionor theLIVE/DEADdye (Invitrogen)
and measured by flow cytometry. BMDCs exposed overnight to 25 g of
FD-pLL (per million cells), whether in the presence or absence of LPS, suf-
fered a significant but minor (approximately 5%) drop in viability, while
lowerdosesofpLLhadnoeffect (seeFig. S1 in the supplementalmaterial).All
experiments were carried out with this or a lower dose of pLL.
Measurement of cell responses. IL-10, IL-12p70, IL-12/23p40, tumor
necrosis factor alpha (TNF-), and IL-6 were measured in culture super-
natants by capture enzyme-linked immunosorbent assay (ELISA) using
paired antibodies from BD or R&D. Surface molecules (CD80, CD86,
CD40, major histocompatibility complex class II [MHC-II], and CD11c)
DC Responses to the E. granulosus Larval Coat
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were quantified by flow cytometry using antibodies conjugated to fluores-
cein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll
protein (PerCP), and PE-Cy7 (and appropriate isotype controls) fromBD
or eBioscience. Data were acquired on FacsCalibur or Facs Canto II cy-
tometers and analyzed using the FlowJo package, gating on CD11c
events. When quantifying cell surface molecule expression, the fluores-
cence levels of isotype control stains were subtracted.
In vivo administration of pLL. Female 8-week-old C57BL/6 mice
were inoculated intraperitoneally (i.p.) with 150 g of FD-pLL, 15 g of
LPS from E. coli O127:B8 (Sigma), FD-pLL plus LPS, or vehicle (PBS) in
200-l volumes in all cases. The procedure was approved by the Univer-
sidad de la República’s Animal Experimentation Committee (CHEA pro-
tocol 050510). Either 3 or 18 h later, as indicated, mice were killed, and
peritoneal cells were retrieved and analyzed by flow cytometry. DCs were
defined as CD19 F4/80 CD11cMHC-II cells or simply as CD11c
MHC-II cells, as the two definitions were found to be clearly equivalent
(as shown in Results). The antibodies used were the same as those men-
tioned above. In addition, peritoneal contents, retrieved by instillation of
1 ml of 0.2% (vol/vol) fetal bovine serum in RPMI, were analyzed for
cytokines by ELISA.
Statistics. All results were analyzed by one-way analysis of variance
(ANOVA), with a Tukey posttest. Overall P values are given in the figure
legends, and significant differences between treatments/groups are shown
in the figures. In addition, for the in vivo experiments only, groups were
compared across repeated experiments by the restricted maximum-like-
lihood (REML) method with a Tukey posttest. The REML method is the
preferred method for two-way analysis of data when random variations
across experiments are expected (28). Hence, for in vivo experiments, in
addition to the intraexperiment differences, significant differences across
repeat experiments are shown in the figures.
RESULTS
The LL breaks either parallel or perpendicular to its natural
laminations, depending on the pulverizationmethod. The LL is
a physically robust macroscopic structure. Blending the LL in its
native (hydrated) form or pulverizing it under liquid nitrogen
gave rise mostly to particles far too large for cells to phagocytose.
In order to obtain preparations that included particles susceptible
to uptake and thereby of similar size to those observed in peripa-
rasitic host macrophages in vivo (25, 26), we pulverized LL mate-
rial that had been previously dehydrated. We tried two different
dehydration methods, namely, exposing the material to ethanol
and then acetone (EA-pLL) and freeze-drying (FD-pLL). The fine
powders obtained were rehydrated, yielding aqueous suspensions
of particles similar in appearance to the native LL gel. We also
generated particles without an intervening dehydration-rehydra-
tion step by shredding, followed by sonication (SS-pLL). In spite
of the 23-m-filtering step applied, pLL preparations consistently
contained some particles whose size exceeded the cutoff of the
filter used (Fig. 1). This was likely due to a tendency of the LL to
split into flat and highly flexible particles that could pass through
the pores end-on and/or in folded conformations. Whereas par-
ticles in EA-pLL or SS-pLL seemed to be generated from individ-
ual “laminations,” those in FD-pLL tended to consist of “stacks of
laminations.” We hypothesize that the LL has an intrinsic ten-
dency to generate flat particles upon disruption, likely because its
strata, or laminations, tend to separate from each other readily.
FIG 1 The LL tends to give rise to flat particles upon disruption. Shown are fluorescencemicroscopy images of the native LL (a paraffin-embedded section from
a natural cattle infection) (a) and pLL preparations (b). The images are of pLL prepared by the three methods explained in the text (FD-, EA-, and SS-pLL); note
that the laminations present in the native LL are observed only in FD-pLL. Also shown are FD-pLL preparations subjected to reduction/alkylation of disulfides
(DTT/IAA) or oxidation of carbohydrate residues with periodate (followed by reduction of aldehydes with borohydride). In both panels, the samples have been
labeled with the lectin PNA conjugated to FITC for easier visualization. Periodate oxidation abrogates PNA binding, as expected, but the physical preparation of
thematerial does not change, as can be observed in the clear-field image (inset). The pLL preparations shown are of bovine host origin, except for SS-pLL, which
is from a mouse host.
Casaravilla et al.
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For unknown reasons, this tendency is not apparent when the LL
is pulverized after freeze-drying.
Exposure to pulverized LL alters the cytokine response to
TLR agonists of DCs. BMDCswere incubated overnight with dif-
ferent doses of pLLwith or without TLR agonists in order to assess
whether pLL had the capacity to alter inflammatory processes.
Exposure to pLL on its own did not induce secretion of IL-12/
23p40, IL-12p70, or IL-10 (Fig. 2), nor did it elicit TNF- or IL-6
(data not shown). In addition to indicating that LLmucins do not
activate DCs in a similar way to TLR agonists, this also shows that
the pLL preparation effectively excludes contamination by envi-
ronmental pyrogens, as independently determined by the LAL
method (see Materials and Methods). When the cells were ex-
posed to pLL followed by a TLR4 or a TLR2 agonist (LPS or
Pam3CSK, respectively), secretion of IL-12/23p40 and IL-12p70
was strongly inhibited, while that of IL-10 was strikingly elevated
in a dose-dependent manner (Fig. 2). The same bias in IL-12 and
IL-10 responses was observed when pLL-conditioned DCs were
stimulated with a heat-killed preparation of the Gram-positive
bacterium P. acnes (data not shown). Levels of TNF- and IL-6
induced by TLR agonists were not significantly biased by exposure
to pLL (data not shown). Similar effects on IL-10 and IL-12/23p40
were observed in bone marrow-derived macrophages (BMDMs)
stimulated with LPS or P. acnes (data not shown).
The effects on BMDC cytokine responses were present in pLL
prepared from material derived from two different host species
(Fig. 3a), supporting a parasite- rather than host-derived activity.
Also, importantly, the effects were present in pLL prepared by
FIG 2 pLL potentiates the production of IL-10 and inhibits that of IL-12/23p40 and IL-12p70 in BMDCs stimulated with TLR agonists. BMDCs were incubated
with the doses of FD-pLL indicated (g) and stimulated with either LPS or Pam3CSK, and cytokine levels in the supernatants were measured. The error bars
indicate the standard deviations (SD) of triplicate wells. ANOVA gave overall P values of0.0001 for all the stimulus-response combinations shown. The results
shown are representative of at least 6 (LPS) or 3 (Pam3CSK) independent experiments. The asterisks denote differences with respect to stimulation with TLR
agonist alone. ***, P 0.001; *, P 0.05.
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the three different methods mentioned above (Fig. 3b). This
shows that the activities are present in finely divided LL irre-
spective of the physical presentation of the particles. It also dem-
onstrates that the activities are not generated as a result of dehy-
dration-rehydration and are not susceptible to denaturation by
organic solvents. Because pLL contains both phagocytosable and
nonphagocytosable particles, we tested both phagocytosable
0.8-mpolystyrene latex beads and nonphagocytosable Sephadex
G-100 (29) to assess if uptake of particles was responsible for the
observed results. Neither type of control particle caused biases in
IL-10 or IL-12/23p40 responses to LPS (Fig. 3c). The effects of pLL
on cytokine responses required contact between the cells and the
particles (Fig. 4a). The effects were absent in the presence of the
actin polymerization inhibitor cytochalasin D, although interpre-
tation of this result is complicated by the fact that the inhibitor by
itself had effects similar to those of pLL (Fig. 4b).
Our experimental system preincubated BMDCs with pLL, fol-
lowed by addition of TLR agonists 1 h later. We next analyzed the
influence on DC cytokine production of pLL added at different
times before or after the addition of LPS. The effects were gener-
ally strongest when pLL was added 1 to 2 h before the TLR agonist
or at the same time (Fig. 5). Addition of pLL 1 h after the TLR
agonist had a weaker, though still discernible, effect. These results
indicate that the effects of pLL on cells arise rapidly.
When injected i.p. into mice, pLL by itself did not elicit IL-10
or IL-12/23p40 detectable in peritoneal lavage fluid (see Fig. S2 in
the supplemental material), consistent with the in vitro results.
Also consistent with those results, when coinjected with LPS, pLL
caused an important potentiation of the IL-10 response.However,
IL-12/23p40 was also potentiated (albeit to a lesser degree than
IL-10) rather than inhibited, suggesting that non-DC cell types
contribute to the in vivo responses to pLL.
In summary, exposure to pLLdoes not elicit IL-12, IL-10, IL-6, or
TNF- responses fromBMDCsbut conditions the cells to respond to
TLR agonists with an anti-inflammatory cytokine profile.
Exposure to pLL causes upregulation of CD86 and inhibits
upregulation of CD40 in dendritic cells in vitro and in vivo.
An assessment of costimulatory molecules showed that incu-
bation of BMDCs with pLL caused a marked increase in the
expression of CD86 without an accompanying increase in
CD40 (Fig. 6). CD80 was also observed to be upregulated in
response to pLL (Fig. 6), but this upregulation was not consis-
tent among different experiments. The levels of MHC-II were
unaffected (data not shown). As expected, incubation with LPS
FIG 3 pLL affects BMDC cytokine responses irrespective of the host species origin or the pulverization method used to prepare it; control particles do not show
the same activities. BMDCswere incubatedwith the doses of pLL or control particles indicated (g) and stimulatedwith LPS, and levels of IL-10 and IL-12/23p40
in the supernatants were measured. (a) Comparison of FD-pLL prepared from bovine or mouse host materials. (b) Comparison of pLL (from mouse host
material) prepared by the three different methods (FD-, EA-, and SS-pLL). (c) Comparison of FD-pLL (bovine host) to (phagocytosable) 0.8-m polystyrene
latex beads coated with bovine serum albumin (BSA) (Lx) or to (nonphagocytosable) Sephadex G-100 beads (G-100). The error bars indicate the SD of triplicate
wells. ANOVA gave overall P values of 0.0001 (a and b) and 0.001 (c). The results shown are representative of at least 5 (a) or 3 (b and c) individual
experiments. The asterisks denote differences with respect to stimulation with LPS alone. ***, P 0.001; **, P 0.01; *, P 0.05.
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caused increased CD86 and CD40 expression. Preincubation
with pLL strongly inhibited CD40 upregulation in response to
LPS (Fig. 6). Contrasting with this, incubation with pLL before
LPS or other TLR agonists caused additive increases in CD86
expression (Fig. 6 and data not shown). Exposure to pLL also
tended to potentiate CD80 upregulation (Fig. 6), but again, this
was not consistent across experiments. There were no marked
effects on MHC-II expression in the presence of LPS (data not
shown). The capacity of pLL to upregulate CD86 and inhibit
CD40 upregulation was consistently observed with pLL pre-
pared by different methods and from different host species (see
Fig. S3 in the supplemental material), though SS-pLL did not
cause significant upregulation of CD86. Control phagocyto-
sable or nonphagocytosable particles did not have an impact on
CD86 or CD40 expression (see Fig. S3 in the supplemental
material). Similar to the effects on cytokine responses, the ef-
fects of pLL on cell surface molecules were absent in the pres-
ence of cytochalasin D, which by itself had effects similar to
those of pLL (see Fig. S4 in the supplemental material). CD86
upregulation and inhibition of TLR agonist-induced CD40 up-
regulation were also clearly observed in pLL-exposed BMDMs
(data not shown).
In order to obtain an in vivo correlate of these in vitro data,
mice were injected i.p. with pLL and/or LPS, and expression of
costimulatory molecules was assessed 18 h later in peritoneal DCs
(see Fig. S5 in the supplemental material for the gating strategy).
Very similar to what was seen in vitro, DCs from mice inoculated
with pLL showed clear upregulation of CD86 but no upregulation
of CD40; this was accompanied by weak upregulation of CD80
that was not robust from one experiment to the other (Fig. 7).
Upon coinjection with LPS, pLL partially inhibited the upregula-
tion of CD40 in DCs without affecting the upregulation of CD80
and CD86 (Fig. 7). As the sole stimulus, pLL gave rise to a nonsig-
nificant trend toward an increase in the number and percentage of
peritoneal DCs after 18 h; together with LPS, it did not alter the
decrease in DC numbers and percentages caused by this inflam-
matory stimulus (data not shown).
Thus, DCs exposed to pLL upregulated CD86 selectively both
in vitro and in vivo. Additionally, pLL enhanced TLR-stimulated
upregulation of CD86 while inhibiting CD40. Thus, in both the
presence and absence of TLR agonists, pLL conditions DCs to
adopt semimature phenotypes.
The capacity of pLL to condition BMDCs is not due to host
Igs. In spite of the extensive washes with high-ionic-strength so-
lution employed during its preparation, pLL contains host-de-
rived proteins strongly bound to the LL in vivo, mostly Igs. As Fc
receptor  (FcR) cross-linking is known to potentiate IL-10 and
inhibit IL-12 secretion in macrophages (30, 31), it was important
to determine if host Igs contributed to the activation phenotype
induced by pLL. Extraction with an acid (pH 2) buffer removed
well over 90% of the host Igs from pLL of mouse origin without
altering its particulate structure (see Fig. S6a and b in the supple-
mental material). This harsh treatment did not impair the effects
of pLL on IL-10 and IL-12/23p40 secretion in LPS-stimulated
FIG 4 The effects of pLL on BMDC cytokine responses require contact and are not observed in the presence of an actin cytoskeleton inhibitor. BMDCs were
incubated with FD-pLL (25 g) and stimulated with LPS, and cytokine levels in the supernatants were measured. This was carried out comparatively in the
absence or presence of transwell inserts (3m; pLLwas placed below the inserts and the cells above) (a) and in the absence or presence of cytochalasin D (b). The
error bars indicate the SD of triplicate wells. ANOVA gave overall P values of 0.0001. The results shown are representative of 3 (a) or 5 (b) independent
experiments. **, P 0.01; ***, P 0.001.
DC Responses to the E. granulosus Larval Coat
August 2014 Volume 82 Number 8 iai.asm.org 3169
 o
n
 O
ctober 29, 2014 by UNIVERSITY O
F EDINBURG
H
http://iai.asm
.org/
D
ow
nloaded from
 
BMDCs (Fig. 8a). Although the potentiation of IL-10 expression
has been previously reported not to be operative in BMDCs (un-
like BMDMs) (32), we did observe enhanced IL-10 production by
BMDCs responding to high doses of latex beads coated with poly-
clonal human IgG (Fig. 8b; see Fig. S7a in the supplemental ma-
terial). This enhancement was diminished by preincubation of
cells with a blocking antibody to FcRII/III (CD16/CD32). In
contrast, the effects of pLL (of eithermouse or bovine host origin)
were not affected by the blocking antibody (Fig. 8b; see Fig. S7a in
the supplemental material). Further, addition of cytochalasin D
had contrasting effects on the potentiation of IL-10 by pLL or IgG:
while, as previously shown, the actin inhibitor caused pLL to have no
effect, it caused IgG-coated beads to give rise to much stronger po-
tentiation (see Fig. S7b in the supplementalmaterial). In terms of the
capacity to cause CD86 upregulation, extraction of pLL with pH 2
buffer caused a significantdecrease in activity (Fig. 8c).However, and
similar to the data for IL-10, while, as shown in Fig. S4 in the supple-
mentalmaterial, pLLhad positive effects onCD86 expression only in
the absence of cytochalasin D, addition of the inhibitor allowed IgG-
coated latex beads to strongly potentiate CD86 upregulation by LPS
(data not shown). The parasite material’s capacity to inhibit CD40
upregulationbyLPSwasnot affected bypH2extraction andwas also
not imitated by IgG-coated latex beads (Fig. 8c).
These results indicate that host Igs are not responsible for the
capacity of pLL to influence BMDC activation. Together with the
observation that pLL biases BMDC cytokine responses and co-
stimulatorymolecule expression independently of the host species
origin of the preparation, the data strongly suggest that the LL is
intrinsically capable of influencing DC activation independently
of adsorbed host proteins.
The capacity of pLL to bias DC activation is susceptible to
reduction of disulfides, but not to oxidation of carbohydrates.
As mentioned previously, the capacity of pLL to bias BMDC phe-
notype was insensitive to organic solvents. Together with the ob-
servation of onlymarginal sensitivity to incubation at 100°C (for 1
h) (data not shown), this suggested that the activity of pLL is
independent of globular proteins. This fitted our expectation, as
by far themajor exposedmolecular moieties in pLL are themucin
glycans (2, 3, 8). However, oxidation with sodium periodate did
not have an effect on the capacity of pLL to bias BMDC cytokine
responses or costimulatorymolecule expression in comparison to
the mock treatment (Fig. 9, compare periodate/borohydride-
treated pLL with borohydride-treated pLL). Similar results were
obtained with BMDMs (data not shown). In contrast, periodate
treatment abrogated the capacity of pLL to be recognized by the
plant lectins PNA and RCA1 (Fig. 1b; see Fig. S8 in the supple-
mental material). Thus, the native carbohydrate structure appears
not to be crucial for the effects of pLL on DCs.
Given the results described above, we next explored the re-
quirement for protein components for the activity of pLL on
DCs. Nonspecific digestion of pLL with pronase eliminated all
the conventional proteins present in pLL detectable on SDS-
PAGE (including host Ig) without altering the material’s phys-
ical presentation (see Fig. S6a and b in the supplemental mate-
rial). This treatment caused a trend toward lower capacity to
potentiate IL-10, which did not reach statistical significance,
and it did not affect the capacity to inhibit IL-12/23p40 (data
not shown; see Fig. S6c in the supplemental material). Conven-
tional SDS-PAGE does not allow detection of the major struc-
tural components of the LL, i.e., the mucins (7). These mucins
are mostly insensitive to pronase treatment (7), probably as a
result of the dense glycosylation they bear (11, 12). However,
we have previously observed that pronase treatment has a dis-
cernible, albeit weak, effect on LL structure, and a similar but
stronger effect is brought about by reduction of disulfide bonds
using DTT (7).We interpret these results in terms of DTT (and,
less efficiently, pronase) targeting a potential disulfide bond
formed by an unpaired cysteine residue present in the short
nonglycosylated N-terminal extension of one of the LL apomu-
cins (11, 12). We thus assayed the effect of disulfide reduction
on the effects of pLL on DCs. Disulfide reduction significantly
diminished the capacity of pLL to potentiate IL-10 and inhibit
FIG 5 The effects of pLL arise quickly; pLL added after LPS can still shift the
response to the TLR agonist. BMDCs were stimulated with LPS alone or with
LPS and FD-pLL (25g), added at different times with respect to the addition
of LPS. IL-10, IL-12/23p40, and IL-12p70 in the supernatants were measured
18 h after LPS addition. The error bars indicate the SD of triplicate wells.
ANOVA gave overall P values of 0.0001. Only differences in comparison
with the conditions used in the previous figures (pLL added 1 h before LPS) are
indicated with asterisks. The data are representative of 5 (IL-10), 4 (IL-12/
23p40), or 3 (IL-12p70) independent experiments (although in some experi-
ments, the effects of pLL added 4 h before LPS were weaker than those in the
experiment shown). ***, P 0.001; **, P 0.01; *, P 0.05.
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IL-12/23p40; it also gave rise to a clear trend toward dimin-
ished capacities to induce CD86 and to inhibit CD40 upregu-
lation (Fig. 10). Complete abrogation of the effects of pLL on
BMDCs was not achieved with any of several variants of the
treatment tested or by combinations of DTT and pronase treat-
ment (data not shown). Neither pronase digestion (see Fig. S6c
in the supplemental material) nor disulfide reduction (see Fig.
1) caused gross alteration in the particle size or appearance of
pLL under the light microscope. The fact that disulfide reduc-
tion diminishes the effect of pLL on BMDCs probably explains
the observation that borohydride treatment per se (i.e., when
used as a mock treatment, separately from periodate oxidation)
tended to diminish the capacity of pLL to affect the BMDC
phenotype (Fig. 9, compare buffer-treated pLL and borohy-
dride-treated pLL). Indeed, borohydride can affect proteins
through the reduction of disulfide bonds (33).
FIG 6 pLL has different effects on CD86 and CD40 expression. BMDCs were incubated with FD-pLL (25 g) or medium only and then stimulated or not with
LPS and analyzed for surface expression of CD86, CD40, and CD80. ANOVA gave overall P values of0.0001 for CD86 and CD40 and0.001 for CD80. The
histograms are representative of results from triplicate wells, and the error bars indicate the SD of these triplicates. The data shown are representative of at least
6 independent experiments, except that effects of pLL on CD80 were not always significant. **, P 0.01; ***, P 0.001.
FIG 7 pLL induces upregulation of CD86 and interferes with upregulation of CD40 inDCs in vivo. C57BL/6micewere injected i.p. with FD-pLL, LPS, both stimuli, or
vehicle (PBS)only. Eighteenhours later, peritonealDCs (definedasCD11MHC-II cells; see the contourplot at the top andFig. S5 in the supplementalmaterial)were
analyzed for expression of surfacemolecules. Geometricmeans of fluorescence intensity were subtracted from the values of the corresponding isotype controls and log
transformed for statistical analysis. ANOVA gave overall P values of0.0001. The data shown are from 1 experiment representative of 3 independent experiments;
interexperiment statistics are shown (			, P 0.001;		, P 0.01;	, P 0.05), along with intraexperiment ones. ***, P 0.001; **, P 0.01.
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In summary, pLL conditions BMDCs independently of its car-
bohydrates and in amanner that requires intact disulfide bonds in
the material for full potency.
DISCUSSION
The ability to inhibit the expression of proinflammatory cytokines
and costimulatory molecules induced by TLR agonists in DCs or
macrophages appears to be a common feature of helminth para-
sites or their products (34–40). In this sense, the inhibition of TLR
agonist-induced expression of IL-12 and CD40 caused by pLL in
BMDCs is expected. The effects of helminth preparations onTLR-
triggered production of IL-10 range from inhibitory to potentiat-
ing, depending on the helminth extract, TLR agonist, and DC
model/species (34, 36, 41–44). IL-10 is induced by TLR agonists
with delayed kinetics with respect to proinflammatory cytokines
as part of a negative-feedbackmechanism (45). IL-10 triggered by
TLR engagement can also be enhanced through other signaling
pathways (46–48). The pattern of response of BMDCs to pLL sug-
gests analogousmodulation ofNF-
B-dependent responses with-
out NF-
B activation. That exposure to pLL as the sole stimulus
does not cause NF-
B activation is strongly suggested by the ab-
sence of response in cytokines known to be dependent on this
signaling modulus. In this context, what stands out is the obser-
vation that pLL on its own induces, in vitro and in vivo, the up-
regulation of CD86. Selective upregulation of CD86 amongmajor
costimulatory molecules was also reported in DCs exposed to the
excretory-secretory products of the nematode Nippostrongylus
brasiliensis (49). However, in contrast to our experimental system,
this was accompanied by secretion of IL-6 and IL-12/23p40, sug-
gesting that exposure to the N. brasiliensis extract caused some
NF-
B activation. It is tempting to speculate that contact with pLL
induces in myeloid cells an NF-
B-independent pathway leading
to CD86 upregulation. Whatever the pathways engaged in DCs
are, they appear to be shared with macrophages, as bone marrow-
derived macrophages exposed to pLL reacted very similarly to
BMDCs in regard to IL-12, IL-10, TNF-, IL-6, CD80, CD86, and
CD40 (data not shown).
Somewhat surprisingly, the influence of pLL on BMDC activa-
tion appeared to be independent of the carbohydrates present in
the material. It is thus conceivable that the LL carbohydrates may
be inert with respect to systemic innate immunity (although in-
teraction with liver-specific lectins must be considered [3, 50]).
The activity of pLL onmyeloid cells was not due to bound host Igs;
it was, however, strongly diminished by the reduction of disulfide
bonds. The N-terminal extension of the second most highly ex-
pressed LL apomucin subfamily (EGC04254/EGC02904 or
EgrG_002012280, according to transcriptome or genome annota-
tion, respectively [11, 12]; GenBank accession no. CDI70203.1)
FIG 8 The effects of pLL are not due to host Igs. BMDCs were exposed to the materials indicated, and CD86 expression was measured, or they were further
stimulated with LPS as indicated, and cytokines in the supernatants or CD40 expression wasmeasured. (a) IL-10 and IL-12/23p40 after exposure to the indicated
doses of pLL (g), previously subjected or not to acid extraction to release host Igs. (b) IL-10 after exposure to pLL (25 g) or IgG-coated latex beads (Lx-IgG)
(225g), with either stimulus having been added after preincubation of the cells with FcR-blocking antibody or isotype control. BSA-coated latex beads did not
cause potentiation of IL-10 secretion (data not shown), showing that the effect of Lx-IgG is indeed due to FcR cross-linking. (c) CD86 and CD40 after exposure
to pLL (25 g), previously subjected or not to acid extraction or to Lx-IgG (25g). None of the materials tested induced cytokines or CD40 upregulation in the
absence of LPS. FD-pLL, from amouse host, was used throughout. The error bars indicate the SD of triplicate (cytokines) or duplicate (surface molecules) wells.
ANOVA gave overall P values of0.0001 (a) and0.01 (b and c). Significant differences caused by acid extraction of pLL or Fc receptor blocking are indicated
with asterisks; significant differences caused by the presence of untreated pLL are not indicated. The results shown are representative of between 3 and 6
independent experiments. ***, P 0.001; *, P 0.05.
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bearswhat appears to be the only cysteine residue present in the LL
apomucins together. We speculate that this residue may form a
disulfide bond between two apomucinmolecules and that it is this
disulfide that is targeted by dithiothreitol (or borohydride) treat-
ment of pLL. Thus, engagement of a cellular receptor by the disul-
fide-dimerized N terminus of apomucin EgrG_002012280 is an
interesting possibility. On the other hand, as complete abrogation
of the effects of pLL onDCs by disulfide reduction, either alone or
in combination with proteolysis, was not observed, a more com-
plex type of interaction must also be considered. DCs and macro-
phages are now recognized to decode essentially all aspects of par-
ticulate materials they encounter, including size, shape, rigidity,
and microtopography (51). Recognition of pLL as a material
would be in agreement with the lack of capacity of soluble LL
preparations to alter macrophage responses to LPS (reference 23
and our unpublished results). The effects of pLL onDCs evidently
require direct contact. The effects may also need particle internal-
ization, as suggested by experiments using cytochalasin D. How-
ever, further work is needed on this point, as examples exist of DC
responses sensitive to the inhibitor that apparently depend only
on events at the cell surface (52). Also, as the effects of pLL and
those of cytochalasin D per se were qualitatively similar, the pos-
sibility that the parasite material elicits signals that have an impact
on the actin cytoskeleton so that its effects and those of cytocha-
lasin D are redundant cannot be ruled out.
The activation phenotype of BMDCs conditioned by pLL, ei-
ther on its own (CD86medCD80lo CD40 IL-12 IL-10) or in the
additional presence of TLR agonists (CD86hi CD80hi CD40lo IL-
12lo IL-10hi), fall within what has previously been termed “semi-
mature” DCs (53). Such DCs are generally associated with tolero-
genesis, and in particular with the induction of the Tr1 subtype
(FoxP3 IL-10) of regulatory T cells (54). Although the defini-
tion of semimature DCs is fairly broad, the low or absent expres-
sion of CD40 in particular is strongly associated with tolerogenic-
ity (55, 56). The next stage of these studies will determine the
impact of pLL on the ability of DCs to activate T cells.
The results we present in this work are relevant, in the infection
context, to cells encountering materials shed from the LL. In ex-
perimental (BALB/c)mouse infection, both spleen and bloodDCs
(defined as CD11c cells) and macrophages (defined as CD11b
cells) were observed to express CD86 at levels above those of con-
trols (6); CD40 levels have not been studied, and neither has the
phenotype of myeloid cells near the parasite itself. We envisage
that the DC phenotype in larval Echinococcus infections must be
influenced both by LL-derived materials and by soluble, secreted
mediators. The effects of E. granulosusmetacestode secretions on
DCs have not been studied. Cyst fluid, which is normally not
exposed to the host, causes upregulation of activation markers,
production of inflammatory cytokines, and NF-
B activation on
human differentiated monocyte-derived DCs (57, 58). BMDC re-
sponses to in vitrometacestode secretions have been studied for E.
multilocularis (41). The cells do not respond with cytokines and
downregulate MHC-II and CD86 below basal levels; upon subse-
quent challenge with LPS, they show impaired MHC-II, CD86,
IL-12p70, and IL-10 responses. These observations are in broad
agreement with the phenotype observed for local DCs in E. mul-
FIG 9 The activity of pLL is not affected by carbohydrate oxidation. BMDCs were exposed to the indicated doses of FD-pLL (g), previously subjected to
oxidation of carbohydrates with sodium periodate followed by reduction of aldehydes with sodium borohydride; to a mock treatment consisting of reduction
with borohydride only; or to incubation with neutral buffer. The cells were stimulated or not with LPS, as indicated, and CD86 and CD40 expression and IL-10
and IL-12/23p40 in supernatants were measured. None of the preparations induced cytokines or CD40 upregulation in the absence of LPS. The error bars
correspond to SD of triplicate (cytokines) or duplicate (surface molecules) wells. ANOVA gave overall P values of 0.0001 (cytokines), 0.001 (CD86), and
0.01 (CD40). Significant differences caused by the presence of untreated or treated pLL (in comparisonwithmediumalone or LPS alone) are not indicated. The
results shown are representative of 4 independent experiments.
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tilocularis experimental infection (59, 60). Our current study pro-
vides a platform for futurework addressingDC conditioning by E.
granulosus metacestode secretions, as well as examining the phe-
notype of DCs in contact with the larval parasite in infection.
In addition to its role in E. granulosus infection, conditioning
of DCs by pLL is interesting in its own right. pLL is a relatively
simple material that retains its capacity to condition DCs after
heat treatment and oxidation of its major carbohydrate compo-
nent and even keepsmost of this ability after extensive proteolysis.
Particles made from synthetic biomaterials destined for tissue en-
gineering generally elicit proinflammatory cytokines from DCs
and, in consequence, display adjuvanticity toward adsorbed pro-
teins (61). Thus, mimicking the relevant surface properties of pLL
in synthetic biomaterials is an intriguing possibility.
ACKNOWLEDGMENTS
We are grateful to AntonioMalanga (Cátedra de Farmacotecnia, Facultad
de Química, Universidad de la República, Uruguay) for Coulter analysis
of particles, to Madelón Portela (UBYPA, Institut Pasteur, Montevideo,
Uruguay) for proteomic identification of proteins, and to Iris Miraballes
(Polo Tecnológico de Pando, Facultad de Química, Universidad de la
República, Uruguay) for kindly providing IgG- and seroalbumin-coated
latex preparations. We also thank María Noel Álvarez (Facultad de Me-
dicina, Universidad de la República, Uruguay) and Marco Campo and
Ricardo Gazzinelli (Fiocruz, Belo Horizonte, Brazil) for introducing
C.C. to macrophage work. Finally, we thank Juan E. Gil (Facultad de
Medicina, Universidad de la República, Uruguay) for a useful discus-
sion on statistics.
This work was funded by Wellcome Trust Project Grant 092752 (to
A.D., J.E.A., A.M.F., and A.S.M.), as well as by a Royal Society Interna-
tional Joint Project (to A.D. and J.E.A.), a British Council Researcher
Exchange Programme award (toC.C.), and aCSIC (Uruguay) travel grant
and a PEDECIBA Ph.D. scholarship (both to C.C.). J.E.A. and A.S.M. are
also funded by the MRC (United Kingdom).
REFERENCES
1. Brunetti E, White AC, Jr. 2012. Cestode infestations: hydatid disease and
cysticercosis. Infect. Dis. Clin. North Am. 26:421–435. http://dx.doi.org
/10.1016/j.idc.2012.02.001.
2. Díaz A, Casaravilla C, Irigoín F, Lin G, Previato JO, Ferreira F. 2011.
Understanding the laminated layer of larval Echinococcus. I. Structure.
Trends Parasitol. 27:204–213. http://dx.doi.org/10.1016/j.pt.2010.12.012.
3. Díaz A, Casaravilla C, Allen JE, Sim RB, Ferreira AM. 2011. Under-
standing the laminated layer of larval Echinococcus. II. Immunology.
Trends Parasitol. 27:264–273. http://dx.doi.org/10.1016/j.pt.2011.01.008.
4. Rogan MT. 1998. T-cell activity associated with secondary infections and
implanted cysts of Echinococcus granulosus in BALB/c mice. Parasite Im-
munol. 20:527–533. http://dx.doi.org/10.1046/j.1365-3024.1998.00180.x.
5. Allan D, Jenkins P, Connor RJ, Dixon JB. 1981. A study of immuno-
regulation of BALB/cmice by Echinococcus granulosus equinus during pro-
longed infection. Parasite Immunol. 3:137–142. http://dx.doi.org/10.1111
/j.1365-3024.1981.tb00391.x.
6. Pan W, Zhou HJ, Shen YJ, Wang Y, Xu YX, Hu Y, Jiang YY, Yuan ZY,
Ugwu CE, Cao JP. 2013. Surveillance on the status of immune cells after
Echinnococcus granulosus protoscoleces infection in Balb/c mice. PLoS
One 8:e59746. http://dx.doi.org/10.1371/journal.pone.0059746.
7. Casaravilla C, Díaz A. 2010. Studies on the structural mucins of the
Echinococcus granulosus laminated layer. Mol. Biochem. Parasitol. 174:
132–1366. http://dx.doi.org/10.1016/j.molbiopara.2010.07.008.
8. Casaravilla C, Brearley C, Soule S, Fontana C, Veiga N, Bessio MI,
Ferreira F, Kremer C, Díaz A. 2006. Characterization of myo-inositol
hexakisphosphate deposits from larval Echinococcus granulosus. FEBS J.
273:3192–3203. http://dx.doi.org/10.1111/j.1742-4658.2006.05328.x.
9. Irigoín F, Casaravilla C, Iborra F, Sim RB, Ferreira F, Díaz A. 2004.
Unique precipitation and exocytosis of a calcium salt of myo-inositol
hexakisphosphate in larval Echinococcus granulosus. J. Cell. Biochem. 93:
1272–1281. http://dx.doi.org/10.1002/jcb.20262.
FIG 10 The effects of pLL are susceptible to disulfide reduction. BMDCs were exposed to the indicated doses of FD-pLL (g), previously treated with DTT to
reduce disulfide bonds followed by IAA to block the thiols formed (DTT/IAA-treated pLL), or incubated in buffer only (control pLL). Then, CD86 expression
was measured or the cells were additionally stimulated with LPS, and CD40 expression or IL-10 and IL-12/23p40 in supernatants were measured. None of the
preparations induced cytokines or CD40 upregulation in the absence of LPS. The error bars correspond to SD of triplicate (cytokines) or duplicate (surface
molecules) wells. ANOVA gave overall P values of 0.0001 (cytokines) or 0.05 (surface molecules). Significant differences caused by disulfide reduction
applied to pLL are indicated with asterisks; significant differences caused by the presence of untreated pLL are not indicated. The results shown are representative
of at least 4 independent experiments. ***, P 0.001.
Casaravilla et al.
3174 iai.asm.org Infection and Immunity
 o
n
 O
ctober 29, 2014 by UNIVERSITY O
F EDINBURG
H
http://iai.asm
.org/
D
ow
nloaded from
 
10. Irigoín F, Ferreira F, Fernandez C, Sim RB, Díaz A. 2002. myo-Inositol
hexakisphosphate is a major component of an extracellular structure in
the parasitic cestode Echinococcus granulosus. Biochem. J. 362:297–304.
http://dx.doi.org/10.1042/0264-6021:3620297.
11. Parkinson J, Wasmuth J, Salinas G, Bizarro CV, Sanford C, Berriman
M, Ferreira HB, Zaha A, Blaxter M, Maizels RM, Fernández C. 2012. A
transcriptomic analysis of Echinococcus granulosus larval stages: implica-
tions for parasite biology and host adaptation. PLoS Negl. Trop. Dis.
6:e1897. http://dx.doi.org/10.1371/journal.pntd.0001897.
12. Tsai IJ, Zarowiecki M, Holroyd N, Garciarrubio A, Sanchez-Flores A,
Brooks KL, Tracey A, Bobes RJ, Fragoso G, Sciutto E, Aslett M, Beasley
H, Bennett HM, Cai J, Camicia F, Clark R, Cucher M, De Silva N, Day
TA, Deplazes P, Estrada K, Fernandez C, Holland PW, Hou J, Hu S,
Huckvale T, Hung SS, Kamenetzky L, Keane JA, Kiss F, Koziol U,
Lambert O, Liu K, Luo X, Luo Y, Macchiaroli N, Nichol S, Paps J,
Parkinson J, Pouchkina-Stantcheva N, Riddiford N, Rosenzvit M, Sali-
nas G, Wasmuth JD, Zamanian M, Zheng Y, Taenia solium Genome
Consortium, Cai X, Soberon X, Olson PD, Laclette JP, Brehm K,
Berriman M. 2013. The genomes of four tapeworm species reveal adap-
tations to parasitism. Nature 496:57–63. http://dx.doi.org/10.1038
/nature12031.
13. Díaz A, Fontana EC, Todeschini AR, Soulé S, Gonzalez H, Casaravilla
C, Portela M, Mohana-Borges R, Mendonça-Previato L, Previato JO,
Ferreira F. 2009. The major surface carbohydrates of the Echinococcus
granulosus cyst:mucin-typeO-glycans decorated by novel galactose-based
structures. Biochemistry 48:11678–11691. http://dx.doi.org/10.1021
/bi901112q.
14. Lin G, Todeschini AR, Koizumi A, Neves JL, González H, Dematteis S,
Hada N, Previato JO, Ferreira F, Mendonça-Previato L, Díaz A. 2013.
Further structural characterization of the Echinococcus granulosus lami-
nated layer carbohydrates: the blood antigen P1-motif gives rise to
branches at different points of theO-glycan chains. Glycobiology 23:438–
452. http://dx.doi.org/10.1093/glycob/cws220.
15. Conchedda M, Gabriele E, Bortoletti G. 2004. Immunobiology of cystic
echinococcosis. Parassitologia 46:375–380.
16. Vuitton DA, Gottstein B. 2010. Echinococcus multilocularis and its inter-
mediate host: a model of parasite-host interplay. J. Biomed. Biotechnol.
2010:923193. http://dx.doi.org/10.1155/2010/923193.
17. Gottstein B, Dai WJ, Walker M, Stettler M, Muller N, Hemphill A.
2002. An intact laminated layer is important for the establishment of sec-
ondary Echinococcus multilocularis infection. Parasitol. Res. 88:822–828.
http://dx.doi.org/10.1007/s00436-002-0659-7.
18. Breijo M, Anesetti G, Martinez L, Sim RB, Ferreira AM. 2008. Echino-
coccus granulosus: the establishment of the metacestode is associated with
control of complement-mediated early inflammation. Exp. Parasitol. 118:
188–196. http://dx.doi.org/10.1016/j.exppara.2007.07.014.
19. Rausch R. 1954. Studies on the helminth fauna of Alaska. XX. The histo-
genesis of the alveolar larva of Echinococcus species. J. Infect. Dis. 94:178–
186.
20. Irigoín F, Laich A, Ferreira AM, Fernández C, Sim RB, Díaz A. 2008.
Resistance of the Echinococcus granulosus cyst wall to complement activa-
tion: analysis of the role of InsP6 deposits. Parasite Immunol. 30:354–364.
http://dx.doi.org/10.1111/j.1365-3024.2008.01034.x.
21. Irigoín F, Wurzner R, Sim RB, Ferreira AM. 1996. Comparison of
complement activation in vitro by different Echinococcus granulosus ex-
tracts. Parasite Immunol. 18:371–375. http://dx.doi.org/10.1046/j.1365
-3024.1996.d01-112.x.
22. Andrade MA, Siles-Lucas M, Espinoza E, Pérez Arellano JL, Gottstein
B, Muro A. 2004. Echinococcus multilocularis laminated-layer compo-
nents and the E14t 14-3-3 recombinant protein decrease NO production
by activated rat macrophages in vitro. Nitric Oxide 10:150–155. http://dx
.doi.org/10.1016/j.niox.2004.03.002.
23. Steers NJ, Rogan MT, Heath S. 2001. In-vitro susceptibility of hydatid
cysts of Echinococcus granulosus to nitric oxide and the effect of the lami-
nated layer on nitric oxide production. Parasite Immunol. 23:411–417.
http://dx.doi.org/10.1046/j.1365-3024.2001.00385.x.
24. Gottstein B, Hemphill A. 1997. Immunopathology of Echinococcosis.
Chem. Immunol. 66:177–208. http://dx.doi.org/10.1159/000058670.
25. Richards KS, Arme C, Bridges JF. 1983. Echinococcus granulosus equinus:
an ultrastructural study of murine tissue response to hydatid cysts. Para-
sitology 86:407–417. http://dx.doi.org/10.1017/S0031182000050605.
26. Barth TF, Herrmann TS, Tappe D, Stark L, Gruner B, Buttenschoen K,
Hillenbrand A, Juchems M, Henne-Bruns D, Kern P, Seitz HM, Moller
P, Rausch RL, Kern P, Deplazes P. 2012. Sensitive and specific immu-
nohistochemical diagnosis of human alveolar echinococcosis with the
monoclonal antibody Em2G11. PLoS Negl. Trop. Dis. 6:e1877. http://dx
.doi.org/10.1371/journal.pntd.0001877.
27. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N,
Schuler G. 1999. An advanced culture method for generating large quan-
tities of highly pure dendritic cells frommouse bonemarrow. J. Immunol.
Methods 223:77–92. http://dx.doi.org/10.1016/S0022-1759(98)00204-X.
28. SAS Insitute, Inc. 2014. JMP software manual. Mixed and random effect
model reports and options. SAS Insitute, Inc., Cary, NC.
29. Kogiso M, Nishiyama A, Shinohara T, Nakamura M, Mizoguchi E,
Misawa Y, Guinet E, Nouri-Shirazi M, Dorey CK, Henriksen RA,
Shibata Y. 2011. Chitin particles induce size-dependent but carbohy-
drate-independent innate eosinophilia. J. Leukoc. Biol. 90:167–176. http:
//dx.doi.org/10.1189/jlb.1110624.
30. Sutterwala FS, Noel GJ, Clynes R, Mosser DM. 1997. Selective suppres-
sion of interleukin-12 induction after macrophage receptor ligation. J.
Exp. Med. 185:1977–1985. http://dx.doi.org/10.1084/jem.185.11.1977.
31. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. 1998. Reversal of
proinflammatory responses by ligating the macrophage Fcgamma recep-
tor type I. J. Exp. Med. 188:217–222. http://dx.doi.org/10.1084/jem.188.1
.217.
32. Anderson CF, Lucas M, Gutierrez-Kobeh L, Field AE, Mosser DM.
2004. T cell biasing by activated dendritic cells. J. Immunol. 173:955–961.
http://dx.doi.org/10.4049/jimmunol.173.2.955.
33. BrownWD. 1960. Reduction of protein disulfide bonds by sodium boro-
hydride. Biochim. Biophys. Acta 44:365–367. http://dx.doi.org/10.1016
/0006-3002(60)91579-1.
34. Everts B, Hussaarts L, Driessen NN, Meevissen MH, Schramm G, van
der Ham AJ, van der Hoeven B, Scholzen T, Burgdorf S, Mohrs M,
Pearce EJ, Hokke CH, Haas H, Smits HH, Yazdanbakhsh M. 2012.
Schistosome-derived omega-1 drives Th2 polarization by suppressing
protein synthesis following internalization by the mannose receptor. J.
Exp. Med. 209:1753–1767. http://dx.doi.org/10.1084/jem.20111381.
35. Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ,
Fitzsimmons CM, Doenhoff MJ, van der Bosch J, Mohrs K, Haas H,
Mohrs M, Yazdanbakhsh M, Schramm G. 2009. Omega-1, a glycopro-
tein secreted by Schistosoma mansoni eggs, drives Th2 responses. J. Exp.
Med. 206:1673–1680. http://dx.doi.org/10.1084/jem.20082460.
36. Kane CM, Cervi L, Sun J, McKee AS, Masek KS, Shapira S, Hunter
CA, Pearce EJ. 2004. Helminth antigens modulate TLR-initiated den-
dritic cell activation. J. Immunol. 173:7454–7461. http://dx.doi.org/10
.4049/jimmunol.173.12.7454.
37. Kuijk LM, Klaver EJ, Kooij G, van der Pol SM, Heijnen P, Bruijns SC,
Kringel H, Pinelli E, Kraal G, de Vries HE, Dijkstra CD, Bouma G, van
Die I. 2012. Soluble helminth products suppress clinical signs in murine
experimental autoimmune encephalomyelitis and differentially modulate
human dendritic cell activation. Mol. Immunol. 51:210–218. http://dx
.doi.org/10.1016/j.molimm.2012.03.020.
38. MacDonald AS, Straw AD, Bauman B, Pearce EJ. 2001. CD8- dendritic
cell activation status plays an integral role in influencing Th2 response
development. J. Immunol. 167:1982–1988. http://dx.doi.org/10.4049
/jimmunol.167.4.1982.
39. Steinfelder S, Andersen JF, Cannons JL, Feng CG, Joshi M, Dwyer D,
Caspar P, Schwartzberg PL, Sher A, Jankovic D. 2009. The major
component in schistosome eggs responsible for conditioning dendritic
cells for Th2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med.
206:1681–1690. http://dx.doi.org/10.1084/jem.20082462.
40. Terrazas CA, Sanchez-Munoz F, Mejia-Dominguez AM, Amezcua-
Guerra LM, Terrazas LI, Bojalil R, Gomez-Garcia L. 2011. Cestode
antigens induce a tolerogenic-like phenotype and inhibit LPS inflamma-
tory responses in human dendritic cells. Int. J. Biol. Sci. 7:1391–1400.
41. Nono JK, Pletinckx K, Lutz MB, Brehm K. 2012. Excretory/secretory-
products of Echinococcus multilocularis larvae induce apoptosis and
tolerogenic properties in dendritic cells in vitro. PLoS Negl. Trop. Dis.
6:e1516. http://dx.doi.org/10.1371/journal.pntd.0001516.
42. Segura M, Su Z, Piccirillo C, Stevenson MM. 2007. Impairment of
dendritic cell function by excretory-secretory products: a potential mech-
anism for nematode-induced immunosuppression. Eur. J. Immunol. 37:
1887–1904. http://dx.doi.org/10.1002/eji.200636553.
43. Terrazas CA, Gomez-Garcia L, Terrazas LI. 2010. Impaired pro-
inflammatory cytokine production and increased Th2-biasing ability of
dendritic cells exposed to Taenia excreted/secreted antigens: a critical role
DC Responses to the E. granulosus Larval Coat
August 2014 Volume 82 Number 8 iai.asm.org 3175
 o
n
 O
ctober 29, 2014 by UNIVERSITY O
F EDINBURG
H
http://iai.asm
.org/
D
ow
nloaded from
 
for carbohydrates but not for STAT6 signaling. Int. J. Parasitol. 40:1051–
1062. http://dx.doi.org/10.1016/j.ijpara.2010.02.016.
44. van Liempt E, van Vliet SJ, Engering A, Garcia Vallejo JJ, Bank CM,
Sanchez-Hernandez M, van Kooyk Y, van Die I. 2007. Schistosoma
mansoni soluble egg antigens are internalized by human dendritic cells
through multiple C-type lectins and suppress TLR-induced dendritic cell
activation. Mol. Immunol. 44:2605–2615. http://dx.doi.org/10.1016/j
.molimm.2006.12.012.
45. Bode JG, Ehlting C, Haussinger D. 2012. The macrophage response
towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell
Signal. 24:1185–1194. http://dx.doi.org/10.1016/j.cellsig.2012.01.018.
46. Caparrós E, Munoz P, Sierra-Filardi E, Serrano-Gomez D, Puig-Kroger
A, Rodriguez-Fernandez JL, Mellado M, Sancho J, Zubiaur M, Corbi
AL. 2006. DC-SIGN ligation on dendritic cells results in ERK and PI3K
activation and modulates cytokine production. Blood 107:3950–3958.
http://dx.doi.org/10.1182/blood-2005-03-1252.
47. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y,
Geijtenbeek TB. 2007. C-type lectin DC-SIGNmodulates Toll-like recep-
tor signaling via Raf-1 kinase-dependent acetylation of transcription fac-
tor NF-kappaB. Immunity 26:605–616. http://dx.doi.org/10.1016/j
.immuni.2007.03.012.
48. Mourao-Sa D, Robinson MJ, Zelenay S, Sancho D, Chakravarty P,
Larsen R, Plantinga M, Van Rooijen N, Soares MP, Lambrecht B, Reis
e Sousa C. 2011. CLEC-2 signaling via Syk in myeloid cells can regulate
inflammatory responses. Eur. J. Immunol. 41:3040–3053. http://dx.doi
.org/10.1002/eji.201141641.
49. Balic A, Harcus Y, Holland MJ, Maizels RM. 2004. Selective maturation
of dendritic cells by Nippostrongylus brasiliensis-secreted proteins drives
Th2 immune responses. Eur. J. Immunol. 34:3047–3059. http://dx.doi.org
/10.1002/eji.200425167.
50. Hsu TL, Lin G, Koizumi A, Brehm K, Hada N, Chuang PK, Wong CH,
Hsieh SL,DíazA. 2013. The surface carbohydrates of theEchinococcus granu-
losus larva interact selectively with the rodent Kupffer cell receptor. Mol.
Biochem. Parasitol. 192:55–59. http://dx.doi.org/10.1016/j.molbiopara.2013
.12.001.
51. Underhill DM, Goodridge HS. 2012. Information processing during
phagocytosis. Nat. Rev. Immunol. 12:492–502. http://dx.doi.org/10.1038
/nri3244.
52. Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone
ME, Vilaysane A, Mucsi AD, Fong Y, Prenner E, Ling CC, Tschopp J,
Muruve DA, Amrein MW, Shi Y. 2011. Alum interaction with dendritic
cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17:479–
487. http://dx.doi.org/10.1038/nm.2306.
53. Lutz MB. 2012. Therapeutic potential of semi-mature dendritic cells for
tolerance induction. Front. Immunol. 3:123. http://dx.doi.org/10.3389
/fimmu.2012.00123.
54. Mills KH, McGuirk P. 2004. Antigen-specific regulatory T cells—their
induction and role in infection. Semin. Immunol. 16:107–117. http://dx
.doi.org/10.1016/j.smim.2003.12.006.
55. Hochweller K, Anderton SM. 2004. Systemic administration of anti-
gen-loaded CD40-deficient dendritic cells mimics soluble antigen ad-
ministration. Eur. J. Immunol. 34:990–998. http://dx.doi.org/10.1002
/eji.200324782.
56. Martin E, O’Sullivan B, Low P, Thomas R. 2003. Antigen-specific
suppression of a primed immune response by dendritic cells mediated by
regulatory T cells secreting interleukin-10. Immunity 18:155–167. http:
//dx.doi.org/10.1016/S1074-7613(02)00503-4.
57. Kanan JH, Chain BM. 2006. Modulation of dendritic cell differentiation
and cytokine secretion by the hydatid cyst fluid ofEchinococcus granulosus.
Immunology 118:271–278. http://dx.doi.org/10.1111/j.1365-2567.2006
.02375.x.
58. Riganò R, Buttari B, Profumo E, Ortona E, Delunardo F, Margutti P,
Mattei V, Teggi A, Sorice M, Siracusano A. 2007. Echinococcus granulo-
sus antigen B impairs human dendritic cell differentiation and polarizes
immature dendritic cell maturation towards a Th2 cell response. Infect.
Immun. 75:1667–1678. http://dx.doi.org/10.1128/IAI.01156-06.
59. Mejri N, Muller J, Gottstein B. 2011. Intraperitoneal murine Echinococ-
cus multilocularis infection induces differentiation of TGF-beta-
expressing DCs that remain immature. Parasite Immunol. 33:471–482.
http://dx.doi.org/10.1111/j.1365-3024.2011.01303.x.
60. Mejri N, Muller N, Hemphill A, Gottstein B. 2011. Intraperitoneal
Echinococcus multilocularis infection in mice modulates peritoneal CD4
and CD8 regulatory T cell development. Parasitol. Int. 60:45–53. http:
//dx.doi.org/10.1016/j.parint.2010.10.002.
61. Babensee JE. 2008. Interaction of dendritic cells with biomaterials. Semin.
Immunol. 20:101–108. http://dx.doi.org/10.1016/j.smim.2007.10.013.
Casaravilla et al.
3176 iai.asm.org Infection and Immunity
 o
n
 O
ctober 29, 2014 by UNIVERSITY O
F EDINBURG
H
http://iai.asm
.org/
D
ow
nloaded from
 
